USP 175865-59-5 hydrochloridum valganciclovir pro Antivirali
| Productumnomen | Valganciclovir hydrochloride |
| Synonyma | L-Valine,2-[(2-aMino-1,6-dihydro-6-oxo-9H-purin-9-yl)Methoxy]-3-hydroxypropylester,hydrochloride(1:1); amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]-3-hydroxypropyl(2S)-2-amino-3-methylbutanoatehydChemicalbookrochloridehydrato;L-Valine,2-[(2-amino- 1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]3-hydroxypropylester, monohydrochloridehydratorum |
| CAS Non. | 175865-59-5 |
| Aspectus | Alba vel off-alba crystallina pulveris |
| Formulae hypotheticae | C14H22N6O5.HCl |
| M. Pondus | 390.83 |
| Consuetudinem | Pharmaceutical Grade vel Research proposito |
| stipare | Quod per petitio tua |
| Repono | Serva in stricta, levis vasis repugnans in loco frigido |
| Valganciclovir hydrochloride Cas:175865-59-5 | ||
| Items | Standard | Proventus |
| Aspectus | Alba vel off-alba crystallina pulveris | cerussa |
| Lepidium sativum | Infrared effusio: respondet quod vexillum referatAbsorptio Ultraviolet: respondet quod vexillum referatSolutio in aqua (1 in 20) occurrit exigentias probationum pro Chloride | Obsequitur Obsequitur
Obsequitur |
| Isopropyl alcohol | ≤1.0% | 0.13% |
| Aquae | ≤8.0% | 4.5% |
| Metalla gravis | ≤20ppm | Obsequitur |
| Pd | ≤10ppm | 10ppm |
| Residuum in ignitio | ≤0.1% | 0.02% |
| Related immunditias | Valganciclovir: /Ganciclovir: ≤1.5%Guanine: ≤1.5% Methoxymethylguanine: ≤0.3% Isovalganciclovir: ≤0.5% Monoacetoxyganciclovir: ≤0.15% Bis-valine ganciclovir Paschae: ≤0.1% Homologus valganciclovir: ≤0.25% Imp H: ≤0.1% Imp I: ≤0.1% Ganciclovir monopropionatus: ≤0.15% Valganciclovir dimer (stereoisomer A): ≤0.1% Valganciclovir dimer (stereoisomer B): ≤0.1% Valganciclovir dimer (stereoisomer C): ≤0.1% Una alia identified immunditia: ≤0.1% Totalis alia identified immunditia: ≤0.1% Ganciclovir mono-N-methyl valinatus (test 2): ≤0.3% Unius immunditiae unidentificatae (teste 1 et 2): ≤0.1 % Totalis immunditiae unidentificatae (Test 1 et 2): ≤0.25% Totalis immunditiae (teste 1 et test 2): ≤3.0 | /0.02%0.01% 0.04% 0.02% ND 0.04% 0.01% 0.01% 0.004% ND ND ND ND Max 0.04% 0.04%
0.02% Max 0.02% 0.13% 0.78% |
| Diastereomer ratio | 45:55 ad 55:45; | 54:46 |
| Puritas enantiomeric valganciclovir | ≥97.0% | 99.9% |
| Hplc primordium | 97.0%～102.0% | 98.8% |
| conclusio: prosequitur USP40. | ||
Company Information
√ Procuratio accumsan plena experientia in technicis et technicis peritissimis sectatoribus; √ Quality is always our top consideration, Strict QC system; √ 11 annos periti quadrigis venditio educendi; √ Independentes R&D lab; √ Duae officinae GMP terminus signati longi sunt; √ Divites copiarum otiosorum officinarum copia pro project nativus; √ High Efficiency working team with consistent path.
